20948682

Source:http://linkedlifedata.com/resource/pubmed/id/20948682

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036397, umls-concept:C0036421, umls-concept:C0087111, umls-concept:C0205314, umls-concept:C0679622, umls-concept:C1527178
pubmed:dateCreated	2010-10-15
pubmed:abstractText	In recent years, many potential antifibrotic treatment strategies have emerged from molecular studies of systemic sclerosis. Few biologicals have already entered clinical trials and these may hopefully prove to be effective in this progressive, profibrotic disease.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101506841
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1757-5931
pubmed:author	pubmed-author:BeyerChristianC, pubmed-author:DistlerJörg HwJH
pubmed:issnType	Electronic
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:year	2009
pubmed:articleTitle	The scientific basis for novel treatments of systemic sclerosis.
pubmed:affiliation	Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg Universitätstrasse 27, 91054 Erlangen Germany.
pubmed:publicationType	Journal Article